Urinary Tract Infection clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy
Sorry, not yet accepting patients
The goal of this non-inferiority randomized controlled trial: is to test the hypothesis that the that there is no additional benefit from a longer course (7 days) versus a shorter course (2 days) of pre-operative antibiotics in patients with moderate to high risk of infection undergoing ureteroscopy. The main questions it aims to answer are: 1. Determine the safety and efficacy of a short course (2 days) as compared to a long course (7 days) 2. Identify secondary predictors of post-operative infectious complications
San Francisco, California
Our lead scientists for Urinary Tract Infection research studies include Thomas Chi, MD, MBA.
Last updated: